Unveiling the Regulatory Mechanism of Nimotuzumab on PD-L1 Expression in Head and Neck Squamous Cell Carcinoma Patients: Implications for Enhanced Anticancer Treatment Strategies.
Cellular Signalling（2024）
Key words
Nimotuzumab,Programmed death ligand 1 (PD-L1),Head and neck squamous cell carcinoma (HNSCC),MEK/ERK,IFN-gamma
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined